Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2204
https://www.valueinhealthjournal.com/article/S1098-3015(16)33570-7/fulltext
Title :
Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33570-7&doi=10.1016/j.jval.2016.09.2204
First page :
A731
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2089